Status:
WITHDRAWN
DELPhI Evaluation of Psychiatric Conditions
Lead Sponsor:
QuantalX Neuroscience
Conditions:
Major Depressive Disorder
Bi-Polar Disorder
Eligibility:
All Genders
18+ years
Brief Summary
DELPhI acquisition and analysis software, a QuantalX Neuroscience development, which is designed to measure, analyze, and display brain electrical activity of human electroencephalogram (EEG), to tran...
Detailed Description
Psychiatric conditions requiring pharmaceutical treatment include Schizophrenia and other psychotic disorders, Major depressive disorder, Bi-polar disorder, Post Traumatic Stress Disorder, Obsessive C...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adult male and female patients between the age of 18-80 years old.
- Patients willing to participate with all of the study procedures and sign informed consent form.
- A clinical diagnosis of psychiatric condition that requires medication or other intervention (such as brain stimulation or psychological treatment).-study groups.
- Without any psychiatric medications or with stable treatment regimen for the last 2 months-study groups..
- 5. A normal neurological exam- control group.
- Exclusion criteria:
- 1\. Prior known epileptic episode. 2. History of any neurodegenerative disease. 3. Patients with history of other known brain disorder/pathology. 4. Contraindication to MR imaging.
- \-
Exclusion
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03842345
Start Date
March 1 2020
End Date
February 1 2021
Last Update
March 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.